NCT00354757View on ClinicalTrials.gov

CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions
GERD
Interventions
DRUG

rabeprazole

Trial Locations (1)

100

National Taiwan Univeristy Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00354757 - CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing | Biotech Hunter | Biotech Hunter